NEW YORK (GenomeWeb News) – Van Andel Institute next week will formally open its $178 million Phase II research-education project, an expansion of its Grand Rapids, Mich., facility that will nearly triple its laboratory space, allowing it to expand its research and more than triple its staff.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.